Your session is about to expire
← Back to Search
Mobile Health App for Alcoholism
N/A
Waitlist Available
Led By Andrew Quanbeck, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
Study Summary
This trial will see if an app can help people with alcohol use disorder, either with or without monitoring.
Who is the study for?
This trial is for adults over 21 within the UW Health system area who want to cut down on drinking, meet criteria for risky alcohol use, own a smartphone, and are willing to use the A-CHESS app. It's not for those with severe alcohol disorders, current psychosis, immediate hospitalization needs or terminal illness.Check my eligibility
What is being tested?
The study tests three ways of using the A-CHESS mobile app in helping people with alcohol use disorder: self-monitored use; peer-supported monitoring; and clinical integration with a health coach. Participants will be divided into these groups randomly.See study design
What are the potential side effects?
Since this trial involves a mobile health application rather than medication, traditional side effects are not expected. However, users may experience stress or anxiety related to self-monitoring or interacting with peers/health coaches.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of risky drinking days
Secondary outcome measures
Cost of implementation of each intervention arm in US dollars
Number of days health coach/other clinician used the A-CHESS dashboard
Number of healthcare services used in the past 6 months
+14 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Peer supportedExperimental Treatment1 Intervention
Patients will be asked to take the same surveys and have the access to the same information as the self-monitoring group. Patient subjects in this group will have access to discussion boards where they can talk to one another and have the ability to share and see stories of other patients. The only involvement of someone other than patients themselves in the peer-supported group will be by a sponsor (i.e., a dedicated user from the area with a sustained history of successful alcohol reduction). The sponsor will participate in discussion groups and encourage use of the system. Patient-reported feedback will be presented directly to the patient.
Group II: Clinically integratedExperimental Treatment1 Intervention
Patients in the clinically integrated group will receive the same intervention as the peer-supported group aside from three differences: 1) patients have the option to share selected elements of their app data with the University of Wisconsin (UW) Health health coach, 2) the health coach will replace the role of the sponsor in the peer-support group, and 3) patients will have the option to attend an initial 60- to 90-minute and two 30-minute follow-up consultations with the health coach in-person, via phone, or via video chat.
Group III: Self monitoredActive Control1 Intervention
Patients of this group will continue receiving regular care from their physician with no interference from the two experimental groups. Patient subjects will download the app on their Android or Apple smart phone that will direct them to external information hosted on the internet that may help reduce their drinking (e.g., NIAAA resources). For the first 12 weeks, once a week patients can set a weekly goal related to their alcohol use or other health related behaviors (e.g., "I will only drink on Friday this week."). At the end of the week subjects will be prompted to take a weekly survey, which will include questions such as a variation of the brief alcohol monitor (BAM) and timeline followback. Patients will then receive feedback on the amount of drinks they had compared to their goal. Then the patient will set a new goal for the following week. Patients will complete quarterly surveys on the A-CHESS app to assess study outcomes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
A-CHESS peer-supported
2020
N/A
~560
A-CHESS clinically-integrated
2020
N/A
~560
Find a Location
Who is running the clinical trial?
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,361,953 Total Patients Enrolled
University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,166,829 Total Patients Enrolled
Andrew Quanbeck, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
448 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an enrollment period for this research project?
"Affirmative. Per the details on clinicaltrials.gov, this research endeavour is recruiting participants right now; it was first listed on March 23rd 2020 and has been updated as recently as August 16th 2022. This particular trial requires 566 individuals to be recruited from a single location."
Answered by AI
Does the age of 75 years or older disqualify individuals from joining this research project?
"This trial is open to applicants between 21 and 100 years of age. Those under 18 or over 65 can access 39 other trials, while there are 279 studies specifically tailored for them."
Answered by AI
Who are the eligible participants for this clinical trial?
"This research project is in search of 566 individuals aged 21 to 100 with a current drinking problem. They must be willing to learn about reducing their intake, have an Apple or Android device, and demonstrate signs of at-risk alcohol consumption on the AUDIT test. For women, this means consuming 7 drinks over the course of one week as well as 3 in a single day; for men it's 14 total drinks and 4 on any given day."
Answered by AI
How many research participants have enrolled in this clinical experiment?
"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial, first posted on March 23rd 2020 and last updated August 16th 2022, is actively searching for participants. A total of 566 patients will be accepted from a single medical center."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger